Intellipharmaceutics, Par Pharmaceutical expand ADHD drug deal - Pharmaceutical Business Review
Links shared publicly online about this topic.
- 61total visits
Intellipharmaceutics, Par Pharmaceutical expand ADHD drug deal - Pharmaceutical Business Review
contractservices.pharmaceutical-business-review.com —
Intellipharmaceutics International and Par Pharmaceutical have added the development and commercialization of additional strengths of generic Focalin
View full resource at contractservices.pharmaceutical-business-review.com
Most Recently Shared on August 19, 2011 at 8:38 am By:
Intellipharmaceutics, Par Pharmaceutical expand ADHD drug deal http://t.co/RcYAZKl
Advertisement
